Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

As psychedelic medicine inches closer to mainstream acceptance, researchers have tackled a crucial question: How many ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

According to Rab, psilocybin-assisted treatment currently has a breakthrough designation with the FDA, meaning that it will ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

Psychedelic-assisted therapy is a combined method that uses psychotherapy and pharmacotherapy with the help of psychedelics ...

AI and psychedelic medicine are merging, with research showing AI's role in drug discovery, trials, and personalized mental ...

Trippy: The Peril and Promise of Medicinal Psychedelics” looks at both the Indigenous use and modern research behind psychoactive substances.

Althea, a Boulder-based company, has created software they hope will become the de facto system for providers of ...

Introduction In recent years, psilocybin, a naturally occurring psychedelic compound found in certain mushrooms, has garnered ...

Atai Life Sciences N.V. ( (ATAI) ) has released its Q3 earnings. Here is a breakdown of the information Atai Life Sciences N.V. presented to ...

How can benefits from psychedelics be expanded despite the rejection of Question 4? And should the legislature try to reverse ...